









Mercados
/
Ações
/
nasdaq-ci
/

Cigna Group

317.400USD

+1.970+0.62%

Fechamento 06/13, 16:00（ET）Cotações atrasadas em 15 min

85.67BValor de mercado

24.95P/L TTM



Cigna Group

317.400

+1.970+0.62%

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Informações da empresa

Código da empresaCI

Nome da EmpresaCigna Group

Data de listagemApr 01, 1982

Fundado em2018

CEOMr. David M. Cordani, CPA

Número de funcionários73500

Tipo de títulosOrdinary Share

Fim do ano fiscalApr 01

Endereço- -

Cidade- -

Bolsa de valoresNYSE Consolidated

País- -

Código postal- -

Telefone- -

Site- -

Código da empresaCI

Data de listagemApr 01, 1982

Fundado em2018

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

64.33K

+18.95%

Ms. Donna F. Zarcone, CPA

Independent Director

26.73K

+2.44%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+2.83%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President, Chief Health Officer and Chief Transformation Officer

17.82K

+97.02%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

6.11K

+11.66%

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

6.11K

+11.66%

Ms. Kathleen M. Mazzarella

Independent Director

6.11K

+11.66%

Ms. Kimberly A. Ross

Independent Director

4.51K

+16.47%

Mr. George Kurian

Independent Director

3.78K

+20.32%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

64.33K

+18.95%

Ms. Donna F. Zarcone, CPA

Independent Director

26.73K

+2.44%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+2.83%

Dr. David J. Brailer, M.D., Ph.D.

Executive Vice President, Chief Health Officer and Chief Transformation Officer

17.82K

+97.02%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

6.11K

+11.66%

Detalhamento da receita

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

Pharmacy revenues

185.36B

0.00%

Network revenues

105.34B

0.00%

Home delivery and specialty revenues

72.48B

0.00%

Fees and other revenues

14.79B

0.00%

Other revenues

11.54B

0.00%

Intercompany eliminations

-4.06B

0.00%

Sem dados

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Pharmacy revenues

185.36B

0.00%

Network revenues

105.34B

0.00%

Home delivery and specialty revenues

72.48B

0.00%

Fees and other revenues

14.79B

0.00%

Other revenues

11.54B

0.00%

Intercompany eliminations

-4.06B

0.00%

Distribuição de ações

Atualizado em: sex, 21 de fev

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

9.74%

BlackRock Institutional Trust Company, N.A.

4.97%

State Street Global Advisors (US)

4.67%

T. Rowe Price Associates, Inc.

4.36%

MFS Investment Management

4.23%

Other

72.03%

Investidores

Proporção

The Vanguard Group, Inc.

9.74%

BlackRock Institutional Trust Company, N.A.

4.97%

State Street Global Advisors (US)

4.67%

T. Rowe Price Associates, Inc.

4.36%

MFS Investment Management

4.23%

Other

72.03%

Tipos de investidores

Investidores

Proporção

Investment Advisor

43.04%

Investment Advisor/Hedge Fund

39.71%

Research Firm

2.47%

Pension Fund

2.25%

Bank and Trust

1.80%

Sovereign Wealth Fund

1.28%

Hedge Fund

1.27%

Corporation

1.19%

Individual Investor

0.39%

Other

6.60%

Participação acionária institucional

Atualizado em: dom, 19 de jan

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q1

2942

254.24M

95.14%

-4.47M

2024Q4

2993

255.45M

93.32%

-4.13M

2024Q3

2931

253.73M

90.72%

-10.03M

2024Q2

2910

254.99M

91.23%

-15.89M

2024Q1

2865

261.02M

89.38%

-14.30M

2023Q4

2815

267.28M

91.36%

-8.83M

2023Q3

2725

267.63M

91.08%

-13.20M

2023Q2

2737

270.13M

91.28%

-8.82M

2023Q1

2710

268.83M

90.70%

-14.56M

2022Q4

2688

273.82M

91.52%

-15.33M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

25.98M

9.58%

+22.81K

+0.09%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

13.39M

4.94%

+8.80K

+0.07%

Dec 31, 2024

State Street Global Advisors (US)

12.72M

4.69%

-105.73K

-0.82%

Dec 31, 2024

T. Rowe Price Associates, Inc.

10.56M

3.9%

-1.12M

-9.58%

Dec 31, 2024

MFS Investment Management

11.23M

4.14%

+489.58K

+4.56%

Dec 31, 2024

Fidelity Management & Research Company LLC

9.98M

3.68%

-1.68M

-14.38%

Dec 31, 2024

Dodge & Cox

8.77M

3.24%

-16.81K

-0.19%

Dec 31, 2024

Sanders Capital, LLC

8.05M

2.97%

+154.42K

+1.95%

Dec 31, 2024

Geode Capital Management, L.L.C.

5.96M

2.2%

+101.74K

+1.74%

Dec 31, 2024

GQG Partners, LLC

4.02M

1.48%

+737.10K

+22.44%

Dec 31, 2024

Ver Mais

ETFs Relacionados

Atualizado em: sex, 6 de jun

Nome

Proporção

iShares U.S. Healthcare Providers ETF

11.44%

VictoryShares Free Cash Flow ETF

3.59%

Monarch Dividend Plus Index ETF

3.25%

VictoryShares US Multi-Factor Minimum Vol ETF

3.12%

Fidelity Blue Chip Value ETF

3.03%

Davis Select US Equity ETF

2.92%

Brandes US Value ETF

2.83%

Fidelity Fundamental Large Cap Value ETF

2.42%

Invesco S&P 500 Enhanced Value ETF

2.41%

iShares Large Cap Value Active ETF

2.29%

Ver Mais

iShares U.S. Healthcare Providers ETF

Proporção11.44%

VictoryShares Free Cash Flow ETF

Proporção3.59%

Monarch Dividend Plus Index ETF

Proporção3.25%

VictoryShares US Multi-Factor Minimum Vol ETF

Proporção3.12%

Fidelity Blue Chip Value ETF

Proporção3.03%

Davis Select US Equity ETF

Proporção2.92%

Brandes US Value ETF

Proporção2.83%

Fidelity Fundamental Large Cap Value ETF

Proporção2.42%

Invesco S&P 500 Enhanced Value ETF

Proporção2.41%

iShares Large Cap Value Active ETF

Proporção2.29%

Dividendo

Um total de 5.74B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Jan 30, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option

Mar 05, 2025

Mar 20, 2025

Mar 05, 2025

Oct 23, 2024

CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024

Dec 04, 2024

Dec 19, 2024

Dec 04, 2024

Jul 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option

Sep 04, 2024

Sep 19, 2024

Sep 04, 2024

Apr 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option

Jun 04, 2024

Jun 20, 2024

Jun 04, 2024

Feb 02, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option

Mar 06, 2024

Mar 21, 2024

Mar 05, 2024

Oct 25, 2023

CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option

Sep 06, 2023

Sep 21, 2023

Sep 05, 2023

Apr 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option

Jun 07, 2023

Jun 22, 2023

Jun 06, 2023

Feb 03, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option

Mar 08, 2023

Mar 23, 2023

Mar 07, 2023

Oct 26, 2022

CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022

Dec 06, 2022

Dec 21, 2022

Dec 05, 2022

Ver Mais

Desdobramento de ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI



Cigna Group

317.400USD

Cigna Group

317.400

Visão Geral

Empresa